Adam Berger, MD, FACS

Adam Berger, MD, FACS

Contact Dr. Berger

1100 Walnut Street
MOB, Suite 500
Philadelphia, PA 19107

(215) 955-1622
(215) 923-8222 fax

Most Recent Peer-reviewed Publications

  1. Patients with Non-response to Neoadjuvant Chemoradiation for Esophageal Cancer Have No Survival Advantage over Patients Undergoing Primary Esophagectomy
  2. Consecutive case series of melanoma sentinel node biopsy for Lymphoseek compared to sulfur colloids
  3. Association of clinical outcomes in metastatic breast cancer patients with circulating tumour cell and circulating cell-free DNA
  4. Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study (Annals of Surgical Oncology, (2018), 25, 9, (2541-2549), 10.1245/s10434-018-6470-1)
  5. Utility of CT imaging in a novel form of high-dose-rate intraoperative breast radiation therapy
  6. ErbB3 targeting enhances the effects of MEK inhibitor in wild-type BRAF/NRAS melanoma
  7. 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study
  8. Characterization and Optimal Management of High-risk Pancreatic Anastomoses during Pancreatoduodenectomy
  9. A standardized comparison of peri-operative complications after minimally invasive esophagectomy: Ivor Lewis versus McKeown
  10. Response and resistance to paradox-breaking BRAF inhibitor in melanomas in vivo and Ex vivo
  11. Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies
  12. Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum
  13. Monitoring neoadjuvant chemotherapy for breast cancer by using three-dimensional subharmonic aided pressure estimation and imaging with US contrast agents: Preliminary experience
  14. Surgical Apgar score (SAS) predicts perioperative morbidity, mortality, and length of stay in patients undergoing esophagectomy at a high-volume center
  15. Comparative Quantitative Lymph Node Assessment in Localized Esophageal Cancer Patients After R0 Resection With and Without Neoadjuvant Chemoradiation Therapy
  16. VAPC-1 Targeted 64 Cu-TP3805 kit preparation and its evaluation
  17. Completion dissection or observation for sentinel-node metastasis in melanoma
  18. Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer
  19. Incorporation of Procedure-specific Risk into the ACS-NSQIP Surgical Risk Calculator Improves the Prediction of Morbidity and Mortality after Pancreatoduodenectomy
  20. Do intraoperative pyloric interventions predict the need for postoperative endoscopic interventions after minimally invasive esophagectomy?